Episode 271 hosts Dr Felix Li (Cosmetic Doctor based in Singapore) and Dr Stefania Roberts (Phlebologist & Cosmetic Doctor based in Melbourne, Australia)

In 'The Tox Talks' episodes we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.

In chapter 9 we discuss a new on label indication for Botox (by Allergan Aesthetics, an Abbvie Company) - Masseter Muscle Prominence (MMP). This was recently approved in China at an event in Shanghai and it's the first and only toxin brand to be approved for this particular indication.

We discuss:

• What MMP is
• The difference between on VS off label indications
• Why having a standardised technique is so important
• What patients want when it comes to MMP
• Asian vs caucasian beauty ideals and beauty standards
• The on label dose for MMP
• The technique to treat MMP
• Masseter anatomy
• The role of ultrasound in assessing the masseter
• Risks and precautions when it comes to treating MMP

ALL IA LINKS & CONTACT INFORMATION